Quality of life and quality of care for patients with gout.
Significant pain, activity limitation, and disability in patients with acute and chronic gouty arthritis lower health-related quality of life. Although many effective therapies are available for gouty arthritis, medication errors are common. One goal of therapy is to reduce the frequency of gout flares by lowering serum uric acid. Further, evidence suggests that the quality of care provided to patients with gout may also impact health-related quality of life. This article reviews evidence concerning quality of care and quality of life for patients with gout.
Singh
Jasvinder A
JA
Rheumatology Section, Medicine Service, VA Medical Center, Rheumatology (111R), One Veteran's Drive, Minneapolis, MN 55417, USA. jasvinder.md@gmail.com
D000493:Allopurinol / Q000627:therapeutic use; D003695:Delivery of Health Care / Q000592:standards*; D004185:Disability Evaluation; D005260:Female; D006073:Gout / Q000188:drug therapy / Q000503:physiopathology / Q000523:psychology*; D006074:Gout Suppressants / Q000627:therapeutic use*; D006304:Health Status; D006801:Humans; D008297:Male; D008508:Medication Errors; D017063:Outcome Assessment, Health Care; D017410:Practice Guidelines as Topic; D011237:Predictive Value of Tests; D011788:Quality of Life / Q000523:psychology*; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014527:Uric Acid / Q000097:blood
D006074:Gout Suppressants; D014527:Uric Acid; D000493:Allopurinol